Developing evolution-resistant drugs for COVID-19

Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus.

Detalles Bibliográficos
Autor principal: Weinreich, Daniel M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Evolutionary Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322998/
https://www.ncbi.nlm.nih.gov/pubmed/35880850
http://dx.doi.org/10.7554/eLife.81334
_version_ 1784756441915064320
author Weinreich, Daniel M
author_facet Weinreich, Daniel M
author_sort Weinreich, Daniel M
collection PubMed
description Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus.
format Online
Article
Text
id pubmed-9322998
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher eLife Sciences Publications, Ltd
record_format MEDLINE/PubMed
spelling pubmed-93229982022-07-27 Developing evolution-resistant drugs for COVID-19 Weinreich, Daniel M eLife Evolutionary Biology Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus. eLife Sciences Publications, Ltd 2022-07-26 /pmc/articles/PMC9322998/ /pubmed/35880850 http://dx.doi.org/10.7554/eLife.81334 Text en © 2022, Weinreich https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Evolutionary Biology
Weinreich, Daniel M
Developing evolution-resistant drugs for COVID-19
title Developing evolution-resistant drugs for COVID-19
title_full Developing evolution-resistant drugs for COVID-19
title_fullStr Developing evolution-resistant drugs for COVID-19
title_full_unstemmed Developing evolution-resistant drugs for COVID-19
title_short Developing evolution-resistant drugs for COVID-19
title_sort developing evolution-resistant drugs for covid-19
topic Evolutionary Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322998/
https://www.ncbi.nlm.nih.gov/pubmed/35880850
http://dx.doi.org/10.7554/eLife.81334
work_keys_str_mv AT weinreichdanielm developingevolutionresistantdrugsforcovid19

Ejemplares similares